IMV Inc. Q4 2022 Financial Results and Operational Updates

IMV Inc. presented fourth quarter 2022 financial and operational results on March 16, 2023, including updates on the VITALIZE clinical trial and DPX delivery platform progress. The presentation addresses the company's immunotherapy candidates, cash runway extending into the second half of 2023, and strategic review process for potential transactions.